AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
How ChatGPT pinpointed Iranian missile strikes with just Google and the news
2
Remote work’s dark side: The Soham Parekh story
3
High-tech’s hidden unemployment crisis: Veteran workers hit hard
4
Fab38 freeze: Intel’s big manufacturing bet collides with harsh market reality
5
Mapping Israel’s cybersecurity ecosystem: Funding doubles despite global headwinds
More news

Nasdaq

20 stories about Nasdaq
מייסדי JFrog מימין שלומי בן חיים פרד סימון ו יואב לנדמן

JFrog ready to enter Nasdaq with a bang

16.09.20|Meir Orbach
The Israeli DevOps company is selling shares to the public at $44 per share, which gives the company a valuation of almost $4 billion and makes it one of the largest IPOs of recent years by an Israeli technology firm
JFROG שלומי בן חיים יואב לנדמן פרד סימון

Israel’s JFrog targeting $475 million at $4 billion valuation in Nasdaq IPO

14.09.20|Meir Orbach
The DevOps technology company increased the range of the 11.6 million shares on offer to $39 to $41 from a prior $33 to $37
נאסד"ק וול סטריט

Wave of tech startups entering Nasdaq via SPAC backdoor

26.08.20|Viki Auslander
Over recent months tech companies are returning SPACs to their former glory, raising a record $31.3 billion through 70 different listings in 2020
מוסף 50 הסטארטאפים המבטיחים חברת ג'ייפרוג Jfrog מימין שלומי בן חיים פרד סימון ו יואב לנדמן

Israel’s JFrog files plans for $100 million Nasdaq IPO

25.08.20|Meir Orbach
Though the company’s valuation has yet to be announced, in the past it has completed funding rounds at values surpassing $1.5 billion
Ran Poliakine Musashi

After becoming Israel's newest unicorn, what's next for Nanox?

24.08.20|CTech
Despite having yet to earn significant revenue or receiving FDA approval for its lightweight X-ray scanners, the company's shares surged on Nasdaq
רן פוליאקין מנכ"ל ננוקס

Israeli mini X-ray developer Nanox sets terms for $100 million Nasdaq IPO

16.08.20|Meir Orbach
According to its filing with the U.S. Securities and Exchange Commission, the company plans to raise the money by offering 5.9 million shares at a price range of $16 to $18
רן פוליאקין מנכ"ל ננוקס

Will Nanox be the next Israeli hit on Nasdaq?

02.08.20|Meir Orbach
Medical imaging company plans to raise $125 million. The valuation of the company is estimated to be at least $600 million
עמרי לביא מייסד אורקסטרה ו NSO

Founders Group, linked to NSO co-founders revealed as early investor in Vroom

07.07.20|Meir Orbach
Used cars online retailer Vroom recently listed on Nasdaq and is currently traded at a $6.4 billion market cap
עמרי אורגד לומינטי נטוורקס

How economic uncertainty is pushing financial institutions towards alternative data

16.06.20|Omri Orgad
Derived from non-traditional sources for financial information, alternative data is becoming an increasingly important tool for investors, in the aftermath of Covid-19, due to a lack of relevant up-to-date data that reflects the current marketplace in real time
איגוואזיו iguazio מימין אסף סומך ירון חביב ירון שגב

Nasdaq-listed NetApp to incorporate technology by Israeli startup Iguazio

10.06.20|Meir Orbach
Iguazio offers data management services and artificial intelligence tools designed to improve the performance, security, and scalability of machine learning applications
מימין מייסדי Vroom אלון בלוך ו אלי וורטמן

Online Used Car Marketplace Vroom Triples its Aim for Nasdaq IPO to $318 Million

03.06.20|Meir Orbach
The company develops an online direct-to-consumer platform that offers low-mileage reconditioned vehicles
מימין מייסדי Vroom אלון בלוך ו אלי וורטמן

Online Used Car Merchant Vroom Wants to Raise $100 Million on Nasdaq

19.05.20|Meir Orbach
According to its prospectus, the New York-based company made $1.2 billion in revenue in 2019, reporting a total of $143 million in net loss
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
חברת פורסקאוט שנמכרה לקרן הפרייבט אקוויטי

Delisting Will Allow Forescout to Do Things a Public Company Can't, Says Exec

09.02.20|Meir Orbach
Forescout co-founder Oded Comay spoke to Calcalist days after the company's $1.9 billion acquisition
נאסדק

How Will Israel Fare When the Nasdaq Jet Finally Runs out of Fuel

05.02.20|Sophie Shulman
Wall Street just had its strongest decade of gains. Should it crash, would the tech-dependent Israeli economy survive unscathed?
נאסדק

Itamar Medical Closes Nasdaq Public Offering at $40.25 Million

05.02.20|CTech
The medical diagnosis company initially looked to raise $30 million to fund its sales and marketing operations as well as product development and clinical trials
default image

Itamar Medical Upsizes Nasdaq Public Offering to $35 Million

02.02.20|Tzally Greenberg
The Nasdaq and Tel Aviv-listed medical diagnosis company originally planned to raise $30 million
אבישי אברהמי מייסד ו מנכל וויקס wix

Israelis Dream of Big U.S. IPOs, but Are Swallowed by M&As Instead

30.01.20|Sophie Shulman
Over the past two decades, Israeli companies raised just $10 billion on Wall Street, compared to the $380 billion that changed hands as part of M&As. A new Barclays report sheds light on how Israeli companies take on New York
נאסדק

Ayala Pharmaceuticals Headed for Nasdaq IPO

07.01.20|Golan Hazani
The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation
משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Company InMode in Talks for Secondary Offering

23.12.19|Golan Hazani
The Israel-based company listed on Nasdaq in August at a $450 million company valuation but has since reached a $1.3 billion market capitalization
Previous ArticlesMore Articles